Manufacturing & Business Development

Pharmex has a new and emerging project within the European CDMO space and aims to be a global provider of healthcare solutions, based on the key pillars of innovation, high-precision manufacturing and a cost-sensitive approach. For us, quality is paramount.

With a turnkey approach, we offer a wide range of both development and manufacturing services, in order to provide our customers and partners with a carefree complement to their own activities and to add new ideas and solutions to their portfolio.

To do so, we build our day-to-day based on Transparency, Focus, Agility, Accountability and “out of the box” thinking.

Our value proposition:

Pharmex is your value-added partner for:

– A unique solution for pharma, cosmetics and biocides.

– Turnkey approach (from development to delivery)

– EU manufacturing and logistics

Our Mission

Pharmex is committed to improving people’s health and well-being by providing health solutions directly or through strategic alliances.

Our Vision

To be a globally recognized company in the multipurpose manufacturing and commercialization of medicines and value-added pharmaceutical products that offer healthcare solutions to improve the quality of life of patients.

PRODUCTION AREA:

MULTIPURPOSE SITE FOR DEVELOPING AND MANUFACTURING PRODUCTS GLOBALLY

The manufacturing area extends over 7,320 m² (excluding the warehouse) and is divided into two main sections of m²: the GMP section dedicated entirely to the production of medicines; and the non-GMP area, focused on the manufacture of cosmetics and biocides.

Cosmetics: 943.44 m²
Liquids: 900.12 m²
Suppositories: 240.47 m²
Oral Solids: 943.44 m²
Weighting: 485.25 m²
Sampling: 80.69 m²

CERTIFICATIONS:

EUGMP PHARMACEUTICAL INSTALLATIONS

EUGMP
(AEMPS – Spain)

Total surface area: Manufacturing plant:	56.642 m² 24.550 m²
Special Authorisations:	Pharmex has been authorised by the AEMPS in 2020 as a Manufacturer and Importer of Medicinal Products for Human Use and Investigational Medicinal Products.
ISO certification:	ISO 9001 ISO 14001 ISO 22716

Download Brochure

Download Project Grant

COUNTRY REGISTER:

APROVED:

ON-GOING:

COLLABORATION IN RESEARCH AND DEVELOPMENT AND OUT-LICENCING

Leveraging its R&D and manufacturing capabilities, Pharmex offers its partners a range of products with not only renewed and updated dossiers, but also first day generic launch dossiers.

In addition, following its innovation-driven strategy, value-added medicines (VAMs) are also a feature of the portfolio currently under development.

CO-DEVELOPMENT

Pharmex’s strategy includes the opportunity to collaborate with partners willing and able to support product development in different ways:

Financial partner: only willing to co-invest in a given development looking for a cost-benefit sharing relationship
Technology partner: can provide a certain technology that is essential for the development and/or manufacturing of the product
Market partner: can secure marketing volumes that support the investment to be made in the development.

BUSINESS AREAS & SERVICES

PHARMA:

CMO: The multipurpose production facilities offers a wide range of manufacturing solutions under EUGMP environment.
OUT-LICENSING: Providing the partners with technology available for license collaborations in order to support third parties portfolio growth.
I+D: With a pipeline of products in development, Pharmex is open to either dedicated or co-development partnerships.

Download Brochure

COSMETICS:

CMO: Fully dedicated are for the manufacturing of semi-solid and liquid cosmetic products.
I+D: Ability to perform development of tailored cosmetic formulations to third parties.

DISINFECTANTS & SANITIZERS:

CMO: ATEX dedicated area for the manufacture of wide tange of disinfectants and sanitizing products.
I+D: Standardized formulations available for partners to select from and possibility to develop custom made formulation.

Download Brochure

Download Pharmex Product Brochure

PARTNERS

Contact

Fill out the form below and we will respond as soon as possible

I accept the terms and conditions set forth in our privacy policy.
We inform you that PHARMEX uses the data obtained from the contact forms to resolve your queries, as well as to send information that can be considered of a commercial nature. The information that PHARMEX sends refers to what may be of interest to the recipient and at all times is related to PHARMEX products or services and for which the holder has shown some interest.

The legal basis for legality in the processing of data for this purpose is your consent to the consultation, as well as the legitimate interest of PHARMEX for the sending of information that could be considered commercial. Said legitimate interest is weighed by keeping you informed at all times of the possibility of unsubscribing from these shipments and by sending information always related to PHARMEX products and services, about which the holder was interested. These data will not be transferred in any case to third parties.

PHARMEX will keep your data as long as you do not object to its treatment.

Pharmacovigilance Unit

To report an adverse event or complaint contact farmacovigilancia@pharmex.es or call: +34 689 009 866 including, in addition to full details of the adverse reaction, the following information:

– Patient details: Age, sex and country of occurrence.

– Details of the reporting person: Name, address, telephone/email, profession and date.

By sending your notification to farmacovigilancia@pharmex.es you expressly agree that your data will be the responsibility of Pharmex. Your data will be used to analyze your case, follow up, notify the health authorities, and resolve your query. Your data will remain in Pharmex files until the resolution of the case and/or consultation.
You can exercise your rights of access, rectification, deletion, opposition, limitation of processing and portability.
For more information about the treatment of your data, please access Pharmex's privacy policy.